Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring - Wikidata - awgldk - TriplyDB

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

http://www.wikidata.org/entity/Q35689332

about

Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Sustained delivery of commensal bacteria from pod-intravaginal rings.Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.Topical microbicides and HIV prevention in the female genital tract Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.An intravaginal ring for the sustained delivery of antibodies.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.The future of HIV treatment.Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.Vaginal rings for delivery of HIV microbicides.Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220.In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.An intravaginal ring for the simultaneous delivery of multiple drugs.Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Pharmacokinetics of the protein microbicide 5P12-RANTES in sheep following single dose vaginal gel administration.Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc

P2860

Q28550108-3D3CBABA-33B9-42A2-AD43-6E81A7395507 Q30447923-6F9F8E53-A514-4217-A35F-136B09F6D746 Q33554048-5956E78F-B15F-4802-8124-F28438A8F765 Q33622882-92776D4E-2DD6-4023-AE57-48D9FC39B5B5 Q34057568-98FDAA91-A749-428B-9325-5FD08B45DC5B Q34086820-50AE0F43-FA76-4EFD-8F39-6FEFFFFA9821 Q34353780-A1903308-FECE-4CC7-95E3-167C87FF2DE7 Q34389166-42AE5E9E-4613-448D-8DD0-48DAFCFA9D7C Q34495644-98601845-63ED-4C05-AD43-C57334B31FFA Q35133798-C08DA71E-1CDB-4237-B6A0-E64343932BC2 Q35345363-102ACF1C-426E-43C1-8561-58F5EC7B8948 Q36088773-F8CB1429-8F97-4738-9F43-06A5C4EFDA26 Q36096590-2EB600DE-AD5B-459F-90EE-17273D5A1D9C Q36115687-596A323F-33DD-48F8-824B-914CD949405A Q36173112-DB5667AB-F7B7-4565-867D-87F1EBC09B5B Q36286901-36274059-BEB8-455E-B026-EF17D23253FE Q36364164-B8DF16AE-32D1-459E-AE5E-7E8D2AF6C6ED Q36396237-01500718-4014-4BFC-9C03-1CB8955F5ED8 Q36429890-A27987C2-A05C-42CC-A820-C513ABBBADD8 Q36446138-824A4C55-BE6A-4245-8FAB-632D512486FB Q36526657-E266D535-0719-4BF5-B7F1-0335D310AAAF Q36630547-77BD600C-402A-4A21-9B70-EAD02108BC1C Q36666807-77F88B95-E83B-4FBA-8BA8-75459FEBD55F Q36724657-BDDC73FB-3E1F-43E7-AA4C-CBFE22B9AD76 Q36730523-176E1C31-CDF2-4051-9B7C-10708106D982 Q36933498-0FD899C2-7ECB-40D3-96A5-879D491121CB Q37036412-A4943017-D9FD-4264-8A96-09203F6F8502 Q37373727-8815D31C-70B3-4FAE-B98D-422ED28A787F Q37379716-32FBA0BA-D069-459C-ADA3-062BC1F09D79 Q37990037-67C7C724-E7DC-4AC3-83EE-273AB3559637 Q38260862-FE843E7B-5AB2-46BC-9D4B-569C10E70814 Q38636239-DE1DE779-7584-4EAA-88EE-A9242B7F067B Q39063908-95C9574B-5314-47BB-8522-EA5385199C10 Q40086722-BBFB0EFB-B756-4003-B628-2D4CBF478859 Q41923505-744FD368-B587-45A3-9091-5A0612EF8922 Q57162891-4A5AFADF-7BFA-4F5A-A476-154D27B040CF Q58723423-2D91D74C-4303-4D5F-822C-4AA34A99E2E0

P2860

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

http://www.wikidata.org/entity/Q35689332

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@ast

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@en

type

label

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@ast

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@en

prefLabel

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@ast

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@en

P1433

Q35689332-6C7DDB55-2ACC-485A-8EF2-D5CC3EF8C431

P1476

Q35689332-BC14BB19-481D-4469-B7B5-F4747886B860

P2093

Q35689332-1E189AA8-B049-4AD8-AD3F-6A4B5CEE4467

Q35689332-303886A1-79D3-41AC-B93A-5D046CBCF387

Q35689332-72427008-9E33-417A-B8DC-62CB8938E9FA

Q35689332-781DEEA6-A7FE-4D08-9CB1-65C0885983D5

Q35689332-788BD1BB-7E72-4CEA-ABF3-A720D75868C8

Q35689332-96F2F10E-7021-4830-8D87-FC20F9264F70

Q35689332-9F372AB6-A926-4D2E-9C86-3C6BC0B92A74

Q35689332-B1AB9731-DA53-4F38-91AE-DAACFD527103

Q35689332-C899AAFA-60E4-4B7B-8F77-2B2264F653FE

Q35689332-EBD6D3EB-963C-4D95-9108-64BB35BAC5CD

P2860

Q35689332-05253327-055A-411D-8CF1-CE83E795B5B2

Q35689332-056C87D9-2E6A-451A-861F-56D0B316472A

Q35689332-08E4EB56-C400-4D2E-BFA0-EB9079659B60

Q35689332-1C3FB330-DC2B-46A7-A40E-B4A6A43084FB

Q35689332-27E2DC6D-2132-4A57-A750-926D3FBE2481

Q35689332-2D1323DF-FDAE-42A8-9518-556D8129474F

Q35689332-3409ACF0-45B8-4898-BE66-3CAA6A4DB1E9

Q35689332-4301B719-E708-4897-B76F-1F6DA97000F9

Q35689332-48F124E0-36D3-4C6C-9D5E-8C5CA3CF4EF7

Q35689332-4CF0A51D-6E4F-4544-AC45-73E9F5D84FA6

P304

Q35689332-48239CD4-0EF0-421A-87A9-9181A06AF60C

P31

Q35689332-4DD4A482-F130-4137-9BC7-E88A995462A1

P356

Q35689332-8AA16F4F-D153-4447-8F20-FF612A51343C

P407

Q35689332-EF643EFF-6149-4915-BB13-BBA8AEFF3CC7

P433

Q35689332-EAB7885B-66E2-4AC4-B3CC-9EE51DFDC79E

P478

Q35689332-0AB37FE0-E871-4C01-88A8-6121D74442A8

P577

Q35689332-BC86F727-282E-479A-94C8-128C406D73C0

P5875

Q35689332-F43015C5-0881-4C02-BC20-718E80EC73AB

P698

Q35689332-8446AA08-93BB-45E1-9898-5761099A303B

P932

Q35689332-410D1202-C7AA-44DF-B1D2-92979B0C4E9F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring

@en

P2093

Amanda M Malone

http://www.w3.org/2001/XMLSchema#string

Cali Nguyen

http://www.w3.org/2001/XMLSchema#string

David R Friend

http://www.w3.org/2001/XMLSchema#string

Etana Kopin

http://www.w3.org/2001/XMLSchema#string

Irina Butkyavichene

http://www.w3.org/2001/XMLSchema#string

John A Moss

http://www.w3.org/2001/XMLSchema#string

Josh Gilman

http://www.w3.org/2001/XMLSchema#string

Kathleen L Vincent

http://www.w3.org/2001/XMLSchema#string

Marc M Baum

http://www.w3.org/2001/XMLSchema#string

Massoud Motamedi

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data.

Sexually transmitted infections among HIV-1-discordant couples.

A vaginal fluid simulant.

The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques

The development of the rabbit vagina.

An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Antiviral drugs in current clinical use.

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

P304

875-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.05662-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51832853

http://www.w3.org/2001/XMLSchema#string

P698

22123689

http://www.w3.org/2001/XMLSchema#string

P932

3264253

http://www.w3.org/2001/XMLSchema#string